Belpointe Asset Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Belpointe Asset Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,079	Closed	-$17K	–	407
2018 Q1	$17K	Sell	3,079 -105	-3%	-$759	0.01%	346
2017 Q4	$25K	Buy	+3,184	New	+$28.9K	0.01%	455

Other funds holding IPCI

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return